Suppose Pheasant Pharmaceuticals is evaluating a proposed capital budgeting project (project Beta) that will require an initial investment of $3,225,000. The project is expected to generate the following net cash flows: Year Year 1 Year 2 Year 3 Year 4 Cash Flow $275,000 $500,000 $500,000 $450,000 Pheasant Pharmaceuticals's weighted average cost of capital is 10%, and project Beta has the same nisk as the firm's average project. Based on the cash flows, what is project Beta's NPV? O-$1,603,763 O-$2,160,577 O-$1,878,763 $2,254,516 2 254,516 Making the accept or reject decision Pheasant Pharmaceuticals's decision to accept or reject project Beta is independent of its decisions on other projects. If the firm follows the NPV method, it should project Beta. Suppose your boss has asked you to analyze two mutually exclusive projects-project A and project B. Both projects require the same investment amount, and the sum of cash inflows of Project A is larger than the sum of cash inflows of project B. A coworker told you that you don't need to do an NPV analysis of the projects because you already know that project A will have a larger NPV than project B. Do you agree with your coworker's statement? O No, the NPV calculation will take into account not only the projects' cash inflows but also the timing of cash inflows and outflows Consequently, project B could have a larger NPV than project A, even though project A has larger cash inflows. O Yes, project A will always have the largest NPV, because its cash inflows are greater than project B's cash inflows. O No, the NPV calculation is based on percentage returns, so the size of a project's cash flows does not affect a project's NPV. Grade It Now Save & Continue Continue without saving Consider this case Suppose Pheasant Pharmaceuticals is evaluating a proposed capital budgeting project (project Beta) that will require an initial investment of $3,225,000. The project is expected to generate the following net cash flows: Year Cash Flow $275,000 $500,000 $500,000 Year 4 $450,000 Year 1 E Year 2 Year 3 Pheasant Pharmaceuticals's weighted average cost of capital is 10%, and project Beta has the same risk as the firm's average project. Based on the cash flows, what is project Beta's NPV? O-$1,603,763 O $2,160,577 O$1,878,763 O-$2,254,516